Article
A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene.
The Journal of clinical investigation - 1 Apr 1994
Ha V T, Marshall M K, Elsas L J, Pinnell S R, Yeowell H N
Abstract excerpt
In the present study, we have isolated and sequenced the complementary DNAs of two mutant alleles for lysyl hydroxylase (LH) in fibroblasts from one patient (AT750) with Ehlers-Danlos syndrome type VI (EDS VI). We have identified a putative mutation in each allele which may be responsible for the patient's decreased LH (normalized to prolyl hydroxylase) activity (24% of normal). Intermediate levels of LH activity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
